FindTrial
Sign In

A study to assess the ability of certain indices to predict the failure of high flow nasal cannula oxygen therapy when used for respiratory failure due to low oxygen levels.

Predictive ability of ROX index, ROX-HR and HACOR Scale for High Flow Nasal Cannula Failure in Patients with Acute Hypoxemic Respiratory Failure: A Prospective Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057318
Enrollment
80
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Saurabh Taneja
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients above 18 years of age. 2. Both males and females.

Exclusion criteria

Exclusion criteria: 1. Patients with an history of asthma or an exacerbation of chronic obstructive pulmonary disease (COPD). 2. Patients on domiciliary oxygen therapy for more than 7 days. 3. Absence of commitment to pursue full life support measures (Do-not-intubate or Do-not- resuscitate orders). 4. Glasgow coma scale 5. Epistaxis, facial trauma, or recent nasal/facial surgery. 6. Refusal to consent for the study.

Design outcomes

Primary

MeasureTime frame
Failure of HFNC therapy as evidenced by the need of upgradation of respiratory support to mechanical ventilation noninvasive or invasiveTimepoint: At 6 & 12 hours after initiation of HFNC—

Secondary

MeasureTime frame
NILTimepoint: 0—

Countries

India

Contacts

Public ContactDr Dileep N

Sir Ganga Ram Hospital

dileepzeon@gmail.com8095199900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026